Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02920853 · ClinicalTrials.gov registry record · NA

Enhanced Biofeedback for Musculoskeletal Pain

A NA study of Musculoskeletal Pain, sponsored by University of Tul.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02920853: Completed NA study of Musculoskeletal Pain, sponsored by University of Tul.

NCT02920853 is a NA study of Musculoskeletal Pain that has completed, run by University of Tul. The registered enrollment target is 6 participants, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02920853, a NA study of Musculoskeletal Pain, has completed, sponsored by University of Tul.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether a novel, enhanced form of biofeedback can help individuals regulate their chronic musculoskeletal pain more effectively.

Primary Outcome

Self-report ratings of pain intensity, rated using 0-10 Likert-type scales, (i.e., 0 = no pain; 10 = most intense pain).

Conditions Studied

Interventions

  • BEHAVIORAL Biofeedback Training (BT-CPR)
  • BEHAVIORAL Biofeedback Training

Study Locations (1)

Oklahoma

  • University of Tulsa - Tulsa

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2016-09
Est. Completion 2018-08
Phase NA
University of Tul

5 total trials

What the finished NCT02920853 record still lists

NCT02920853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Biofeedback Training (BT-CPR) is the first listed.

NCT02920853 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT02920853 about?

NCT02920853 is a clinical study titled "Enhanced Biofeedback for Musculoskeletal Pain". The purpose of this study is to assess whether a novel, enhanced form of biofeedback can help individuals regulate their chronic musculoskeletal pain more effectively.

What is the current status of trial NCT02920853?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-09. Estimated completion is 2018-08.

What conditions does trial NCT02920853 study?

This clinical trial studies the following conditions: Musculoskeletal Pain.

What interventions are being tested in trial NCT02920853?

The interventions under investigation include: Biofeedback Training (BT-CPR) (BEHAVIORAL), Biofeedback Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02920853?

This trial is sponsored by University of Tul, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02920853 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02920853's enrollment target sits among peer trials

6 38th of 37 the lowest of 37 other Musculoskeletal Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02920853, the US trial registry maintained by the National Library of Medicine. NCT02920853 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.